Sanofi

Media Room

Nadège Bailleul, Mirage Operator, Val de Reuil, France

Second Quarter 2025

Second quarter 2025 results will be reviewed by management during a live audio webcast with the financial community on July 31, 2025. The presentation will be followed by a Q&A session.

15:00 – 16:30 CET (9:00am – 10:30am EDT)

Press releases


June 30, 2025
Press release: Availability of the Q2 2025 Aide mémoire

June 30, 2025
Press Release: Riliprubart granted orphan drug designation in Japan for chronic inflammatory demyelinating polyneuropathy

June 25, 2025
Press Release: Riliprubart earns orphan drug designation in the US for antibody-mediated rejection in solid organ transplantation

Contact Our Media Team

You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.

Publications

Sustainability Statement 2024 (ESG Report)
Download PDF
XBRL Viewer URD 2024
Download PDF
XBRL Viewer 20F 2024
Download PDF
Registration Document 2024 (in French)
Download PDF